A detailed history of Whalen Wealth Management Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Whalen Wealth Management Inc. holds 10,916 shares of NVO stock, worth $1.56 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares
10,916
Previous 9,872 10.58%
Holding current value
$1.56 Million
Previous $1.02 Billion 37.24%
% of portfolio
1.04%
Previous 0.92%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

BUY
$102.11 - $135.92 $106,602 - $141,900
1,044 Added 10.58%
10,916 $1.4 Billion
Q4 2023

Feb 13, 2024

BUY
$87.78 - $105.45 $866,564 - $1.04 Million
9,872 New
9,872 $1.02 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $323B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Whalen Wealth Management Inc. Portfolio

Follow Whalen Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whalen Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Whalen Wealth Management Inc. with notifications on news.